Gomti Research And Pharmachem Private Limited
Gomti Research And Pharmachem Private Limited is a Private Non-govt company company incorporated in 1997 and based in Karnataka, India. Gomti Research And Pharmachem Private Limited operates in Rubber & Plastics (NIC 25110) with authorized capital of ₹20.00 L and paid-up capital of ₹19.90 L. For 2020-21, the company reported revenue of ₹7.19 Cr and profit after tax of ₹9.31 L. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
GOMTI RESEARCH AND PHARMACHEM PRIVATE LIMITED is the legal entity of grpc.co.in.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 26 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +1d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +25d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Gomti Research And Pharmachem Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 594513181 | Axis Bank Ltd(Bank) | ₹2.22 Cr | 12 Mar 2020 | Satisfied |
| 125758188 | HDFC Bank Ltd(Bank) | ₹15.30 Cr | 19 Sep 2019 | Open |
| 549249636 | Kotak Mahindra Bank Ltd(Bank) | ₹18.73 Cr | 19 Sep 2022 | Open |
| 988327261 | HDFC Bank Ltd(Bank) | ₹12.21 Cr | 12 Mar 2021 | Open |
| 759510382 | State Bank of India(Bank) | ₹11.20 Cr | 12 Mar 2022 | Open |
| 789382050 | ICICI Bank Ltd(Bank) | ₹6.98 Cr | 04 Jul 2023 | Open |
Charge IDs, lenders & amounts for Gomti Research And Pharmachem Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — | ||||
| 2014-15 | — |
Detailed Financials
4 FYs| Line item | 2020-21 | 2019-20 | 2018-19 | 2017-18 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2020-21 | -10.0% | -6.0% | +35.0% | |
| Profit after Tax2020-21 | -56.0% | -42.0% | — | |
| Net Worth2020-21 | +3.0% | +8.0% | +8.0% |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2014-15 | +0.33% | — | +1.06% | +0.25% | 4.27 | |||
| 2015-16 | -0.29% | -18.64% | -0.75% | -0.17% | 4.38 | |||
| 2016-17 | +1.33% | +38.42% | +4.66% | +1.04% | 4.46 | |||
| 2017-18 | +2.26% | +48.65% | +10.49% | +2.25% | 4.66 | |||
| 2018-19 | +0.20% | +1.75% | +0.91% | +0.21% | 4.36 | |||
| 2019-20 | +1.79% | -17.96% | +6.46% | +1.25% | 5.16 | |||
| 2020-21 | +1.30% | -5.36% | +4.22% | +0.64% | 6.55 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 4,02,70,925 | 81.04% |
| Institutional Investors | 2 | 13,19,351 | 2.66% |
| Public & Others | 57 | 81,01,274 | 16.30% |
Promoter, institutional & public holding for Gomti Research And Pharmachem Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
3 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.